News

Deal Announcements

AEGEA Medical Clears Series C Financing

Tuesday, May 5, 2015 5:32:00 AM PDT | VentureDeal
   Redwood City, California  --  Medical device technology company AEGEA Medical has received $36 million in its third round of institutional venture capital funding.

AEGEA is commercializing what it calls a "novel treatment for abnormal uterine bleeding."

Investors included Alloy Ventures, Covidien/Medtronic, Delphi Ventures, BioMed Ventures and others.

The company said it would use the funding to complete the submission of its PMA application to market its endometrial ablation procedure.

AEGEA has raised a total of at least $55 million in development financing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1